. Agence-nationale-d, accréditation et d " évaluation en santé. Indications de l " épuration extra-rénale dans l " insuffisance rénale chronique terminale, 1996.

B. Issad, Diabète et Dialyse Péritonéale : Quelles spécificités ?, 2011.

T. Petitclerc, Hémodialyse : principes généraux et modalités de traitement, MT Médecine-Thérapeutique, vol.4, pp.557-66, 1998.

M. Lysaght, E. Vonesh, F. Gotch, L. Ibels, M. Keen et al., The influence of dialysis treatment modality on the decline of remaining renal function, ASAIO Trans Am Soc Artif Intern Organs, vol.37, pp.598-604, 1991.

M. Merkus, K. Jager, F. Dekker, E. Boeschoten, P. Stevens et al., Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment, American Journal of Kidney Diseases, vol.29, issue.4, pp.584-92, 1997.
DOI : 10.1016/S0272-6386(97)90342-5

B. Marrón, A. Ortiz, P. De-sequera, G. Martín-reyes, G. De-arriba et al., Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy???a Spanish multicentre experience, Nephrology Dialysis Transplantation, vol.21, issue.suppl_2, pp.51-56, 2006.
DOI : 10.1093/ndt/gfl191

N. Lameire, Integrated care for ESRD patients, 1999.

M. Dratwa, La prise en charge du sujet âgé en dialyse péritonéale : le paradoxe français, 2011.

. Vrtovsnik, Physiopathologie de la membrane péritonéale. Actual. Néphrologiques Jean Hambg, Necker 2005. Flammarion médecine sciences, 2005.

F. Vrtovsnik and . Perte, Ultra-Filtration en Dialyse péritonéale, 2008.

B. Rippe, A three-pore model of peritoneal transport, Perit Dial Int J Int Soc Perit Dial, vol.13, issue.2, pp.35-43, 1993.

J. Ni, J. Verbavatz, A. Rippe, I. Boisdé, P. Moulin et al., Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis, Kidney International, vol.69, issue.9, pp.1518-1543, 2006.
DOI : 10.1038/sj.ki.5000285

R. Pecoits-filho, S. Mujais, and B. Lindholm, Future of icodextrin as an osmotic agent in peritoneal dialysis, Kidney International, vol.62, pp.80-87, 2002.
DOI : 10.1046/j.1523-1755.62.s81.11.x

L. Van-overmeire, E. Goffin, J. Krzesinski, A. Saint-remy, P. Bovy et al., Peritoneal equilibration test with conventional ???low pH/high glucose degradation product??? or with biocompatible ???normal pH/low glucose degradation product??? dialysates: does it matter?, Nephrology Dialysis Transplantation, vol.13, issue.Suppl 4, pp.1946-51, 2013.
DOI : 10.1152/ajpheart.01364.2005

P. Trolliet, Dialyse péritonéale chez l " adulte : quel type pour quel patient ?

J. Ni, J. Verbavatz, A. Rippe, I. Boisdé, P. Moulin et al., Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis, Kidney International, vol.69, issue.9, pp.1518-1543, 2006.
DOI : 10.1038/sj.ki.5000285

W. Van-biesen, O. Heimburger, R. Krediet, B. Rippe, L. Milia et al., Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group, Nephrology Dialysis Transplantation, vol.17, issue.Suppl_2, pp.2052-62, 2010.
DOI : 10.1046/j.1523-1755.1998.00010.x

J. Passlick-deetjen, A. Gauly, and B. Marzell, Fresenius Medical care. Utilisation des plastifiants dans le traitement par dialyse, Bull Dial Péritonéale, vol.7, 1997.

R. Alsop, History, chemical and pharmaceutical development of icodextrin, Perit Dial, vol.14, pp.5-12, 1994.

C. Mistry, R. Gokal, and E. Peers, A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD, Kidney International, vol.46, issue.2, pp.496-503, 1994.
DOI : 10.1038/ki.1994.300

A. Dawnay and D. Millar, Glycation and advanced glycation end-product formation with icodextrin and dextrose, Perit Dial Int J Int Soc Perit Dial, vol.17, pp.52-60, 1997.

E. Peers, A. Scrimgeour, and A. Haycox, Cost-Containment in CAPD Patients with Ultrafiltration Failure, Clinical Drug Investigation, vol.10, issue.1, pp.53-61, 1995.
DOI : 10.2165/00044011-199510010-00009

N. Posthuma, P. Ter-wee, H. Verbrugh, P. Oe, E. Peers et al., Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance, Nephrology Dialysis Transplantation, vol.12, issue.3, pp.550-553, 1997.
DOI : 10.1093/ndt/12.3.550

B. Rippe and L. Levin, Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD, Kidney International, vol.57, issue.6, pp.2546-56, 2000.
DOI : 10.1046/j.1523-1755.2000.00114.x

A. Olszowska, J. Waniewski, A. Werynski, B. Anderstam, B. Lindholm et al., Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acidbased solutions, Perit Dial Int J Int Soc Perit Dial, vol.27, pp.544-53, 2007.

B. Rippe and D. Venturoli, Peritoneal transport kinetics with amino acid-based and glucosebased peritoneal dialysis solutions, Perit Dial Int J Int Soc Perit Dial, vol.27, pp.518-540, 2007.

L. Martis, M. Patel, J. Giertych, J. Mongoven, M. Taminne et al., Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution, The Lancet, vol.365, issue.9459, pp.588-94, 2005.
DOI : 10.1016/S0140-6736(05)70800-X

E. Goffin, M. Tintillier, and O. Devuyst, Aseptic peritonitis due to peptidoglycan, The Lancet, vol.366, issue.9482, pp.289-90, 2005.
DOI : 10.1016/S0140-6736(05)66976-0

. Agence-de-la-biomédecine, Rapport annuel REIN, 2011.

H. Autorité and D. Santé, Indications et non-indications de la dialyse péritonéale chronique chez l " adulte. HAS, 2007.

P. Durand, APD schedules and clinical results, Contrib Nephrol, pp.272-279, 2003.
DOI : 10.1159/000093622

S. A. Baxter, Information relative au dispoditif médical UV Flash Compact, 2014.

D. Churchill, K. Thorpe, E. Vonesh, and P. Keshaviah, Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group, J Am Soc Nephrol JASN, vol.8, pp.965-71, 1997.

R. Paniagua, D. Amato, S. Mujais, E. Vonesh, A. Ramos et al., Predictive Value of Brain Natriuretic Peptides in Patients on Peritoneal Dialysis: Results from the ADEMEX Trial, Clinical Journal of the American Society of Nephrology, vol.3, issue.2, pp.407-422, 2008.
DOI : 10.2215/CJN.03820907

M. Jansen, A. Hart, J. Korevaar, F. Dekker, E. Boeschoten et al., Predictors of the rate of decline of residual renal function in incident dialysis patients, Kidney International, vol.62, issue.3, pp.1046-53, 2002.
DOI : 10.1046/j.1523-1755.2002.00505.x

J. Ryckelynck, T. Lobbedez, M. Ficheux, C. Bonnamy, E. Haggan et al., Actualit??s en??dialyse p??riton??ale, La Presse M??dicale, vol.36, issue.12, pp.1823-1831, 2007.
DOI : 10.1016/j.lpm.2007.04.038

A. Wang and K. Lai, The importance of residual renal function in dialysis patients, Kidney International, vol.69, issue.10, pp.1726-1758, 2006.
DOI : 10.1038/sj.ki.5000382

B. Marrón, C. Remón, M. Pérez-fontán, P. Quirós, and A. Ortíz, Benefits of preserving residual renal function in peritoneal dialysis, Kidney International, vol.73, 2008.
DOI : 10.1038/sj.ki.5002600

K. Ate?, G. Nergizo?lu, K. Keven, A. Sen, S. Kutlay et al., Effect of fluid and sodium removal on mortality in peritoneal dialysis patients, Kidney International, vol.60, issue.2, pp.767-76, 2001.
DOI : 10.1046/j.1523-1755.2001.060002767.x

E. Brown, S. Davies, P. Rutherford, F. Meeus, M. Borras et al., Survival of Functionally Anuric Patients on Automated Peritoneal Dialysis: The European APD Outcome Study, Journal of the American Society of Nephrology, vol.14, issue.11, pp.2948-57, 2003.
DOI : 10.1097/01.ASN.0000092146.67909.E2

N. Dombros, M. Dratwa, M. Feriani, R. Gokal, O. Heimbürger et al., European best practice guidelines for peritoneal dialysis Adequacy of peritoneal dialysis, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.20, pp.24-31, 2005.

P. Blake, J. Bargman, K. Brimble, S. Davison, D. Hirsch et al., Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy, Perit Dial Int J Int Soc Perit Dial, vol.31, pp.218-257, 2011.

P. Li, C. Szeto, B. Piraino, J. Bernardini, A. Figueiredo et al., PERITONEAL DIALYSIS-RELATED INFECTIONS RECOMMENDATIONS: 2010 UPDATE, Peritoneal Dialysis International, vol.30, issue.4, pp.393-423, 2010.
DOI : 10.3747/pdi.2010.00049

URL : http://www.pdiconnect.com/content/30/4/393.full.pdf

M. Tagnaouti, B. Branger, C. Ied, P. Reboul, B. Zabadani et al., La scl??rose p??riton??ale encapsulante??: aspects actuels, N??phrologie & Th??rapeutique, vol.5, issue.2, pp.122-155, 2009.
DOI : 10.1016/j.nephro.2008.08.014

S. Davies, L. Phillips, P. Naish, and G. Russell, Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis, J Am Soc Nephrol JASN, vol.12, pp.1046-51, 2001.

D. Paolo, N. Garosi, G. Petrini, G. Traversari, L. Rossi et al., Peritoneal dialysis solution biocompatibility testing in animals, Perit Dial Int J Int Soc Perit Dial, vol.15, pp.61-70, 1995.

R. Mactier, T. Sprosen, R. Gokal, P. Williams, M. Lindbergh et al., Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain, Kidney International, vol.53, issue.4, pp.1061-1068, 1998.
DOI : 10.1111/j.1523-1755.1998.00849.x

K. Otte, M. Gonzalez, M. Bajo, G. Del-peso, J. Heaf et al., Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution, Perit Dial Int J Int Soc Perit Dial, vol.23, pp.138-183, 2003.

J. Williams, N. Topley, K. Craig, R. Mackenzie, M. Pischetsrieder et al., The Euro-Balance Trial: The effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane, Kidney International, vol.66, issue.1, pp.408-426, 2004.
DOI : 10.1111/j.1523-1755.2004.00747.x

. Bicarbonate, lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels, Kidney Int, vol.59, pp.1529-1567, 2001.

C. Szeto, K. Chow, C. Lam, C. Leung, B. Kwan et al., Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucosedegradation products--a 1-year randomized control trial, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.22, pp.552-561, 2007.

S. Mortier, D. Faict, C. Schalkwijk, N. Lameire, D. Vriese et al., Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane, Kidney International, vol.66, issue.3, pp.1257-65, 2004.
DOI : 10.1111/j.1523-1755.2004.00879.x

L. Hekking, M. Zareie, B. Driesprong, D. Faict, A. Welten et al., Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution, J Am Soc Nephrol JASN, vol.12, pp.2775-86, 2001.

R. Mackenzie, C. Holmes, S. Jones, J. Williams, and N. Topley, Clinical indices of in vivo biocompatibility: The role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients, Kidney International, vol.64, pp.84-93, 2003.
DOI : 10.1046/j.1523-1755.2003.08809.x

H. Lee, H. Park, B. Seo, J. Do, S. Yun et al., Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance), Perit Dial Int J Int Soc Perit Dial, vol.25, pp.248-55, 2005.

J. Montenegro, R. Saracho, I. Gallardo, I. Martínez, R. Muñoz et al., Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis, Nephrology Dialysis Transplantation, vol.22, issue.6, pp.1703-1711, 2007.
DOI : 10.1093/ndt/gfl848

S. Han, S. Ahn, J. Yun, A. Tranaeus, and D. Han, Mortality and Technique Failure in Peritoneal Dialysis Patients Using Advanced Peritoneal Dialysis Solutions, American Journal of Kidney Diseases, vol.54, issue.4, pp.711-731, 2009.
DOI : 10.1053/j.ajkd.2009.05.014

D. Johnson, F. Brown, M. Clarke, N. Boudville, T. Elias et al., Effects of Biocompatible versus Standard Fluid on Peritoneal Dialysis Outcomes, Journal of the American Society of Nephrology, vol.23, issue.6, pp.1097-107, 2012.
DOI : 10.1681/ASN.2011121201

S. Kim, J. Oh, S. Kim, W. Chung, C. Ahn et al., Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study, Nephrology Dialysis Transplantation, vol.41, issue.6, pp.2899-908, 2009.
DOI : 10.1016/S0272-6386(03)00353-6

M. Haag-weber, R. Krämer, R. Haake, M. Islam, F. Prischl et al., Low-GDP fluid (Gambrosol trio(R)) attenuates decline of residual renal function in PD patients: a prospective randomized study, Nephrology Dialysis Transplantation, vol.21, issue.10, pp.2288-96, 2010.
DOI : 10.1681/ASN.2005020155

T. Martikainen, A. Teppo, C. Gronhagen-riska, and A. Ekstrand, Benefit of Glucose-Free Dialysis Solutions on Glucose and Lipid Metabolism in Peritoneal Dialysis Patients, Blood Purification, vol.258, issue.4, pp.303-313, 2005.
DOI : 10.1016/S0140-6736(63)91500-9

M. Bonomini, D. Liberato, L. , D. Rosso, G. Stingone et al., Effect of an l-Carnitine???Containing Peritoneal Dialysate on Insulin Sensitivity in Patients Treated With CAPD: A 4-Month, Prospective, Multicenter Randomized Trial, American Journal of Kidney Diseases, vol.62, issue.5, pp.929-967, 2013.
DOI : 10.1053/j.ajkd.2013.04.007

M. Bonomini, A. Pandolfi, D. Liberato, L. , D. Silvestre et al., l-Carnitine is an osmotic agent suitable for peritoneal dialysis, Kidney International, vol.80, issue.6, pp.645-54, 2011.
DOI : 10.1038/ki.2011.117

URL : https://doi.org/10.1038/ki.2011.117

B. Rippe, Hyperbranched Polyglycerol: A Future Alternative to Polyglucose in Peritoneal Dialysis Fluids?, Peritoneal Dialysis International, vol.33, issue.1, pp.5-7, 2013.
DOI : 10.3747/pdi.2012.00317

A. Mendelson, Q. Guan, I. Chafeeva, G. Da-roza, J. Kizhakkedathu et al., Hyperbranched Polyglycerol Is an Efficacious and Biocompatible Novel Osmotic Agent in a Rodent Model of Peritoneal Dialysis, Peritoneal Dialysis International, vol.33, issue.1, pp.15-27, 2013.
DOI : 10.3747/pdi.2012.00148

P. Dousdampanis, K. Trigka, and J. Bargman, Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients, International Journal of Nephrology, vol.31, issue.2, pp.424915-424925, 2013.
DOI : 10.1111/j.1440-1797.2009.01186.x

P. Freida, M. Galach, D. Filho, J. Werynski, A. Lindholm et al., Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell, Perit Dial Int J Int Soc Perit Dial, vol.27, pp.267-76, 2007.

P. Li, B. Culleton, A. Ariza, J. Do, D. Johnson et al., Randomized, Controlled Trial of Glucose-Sparing Peritoneal Dialysis in Diabetic Patients, Journal of the American Society of Nephrology, vol.24, issue.11, pp.1889-900, 2013.
DOI : 10.1681/ASN.2012100987

M. Fischbach, B. Issad, V. Dubois, and R. Taamma, THE BENEFICIAL INFLUENCE ON THE EFFECTIVENESS OF AUTOMATED PERITONEAL DIALYSIS OF VARYING THE DWELL TIME (SHORT/LONG) AND FILL VOLUME (SMALL/LARGE): A RANDOMIZED CONTROLLED TRIAL, Peritoneal Dialysis International, vol.31, issue.4, pp.450-458, 2011.
DOI : 10.3747/pdi.2010.00146

. Ilwi, o\U: U' I: r i\T DE llOCTEUM r.N PItAR. \ IAC IE

_. '. O~·-'toi and _. , 12 SEI'. ZlH Do)a ... Il F~. l'loo " 1.01'11" dt l'UIIi